Market Overview
The Middle East animal health market covers products and services for disease prevention, diagnosis, and treatment across livestock, poultry, and companion animal segments. The regional market has grown from approximately $1.23 billion in 2024 to an estimated $1.34 billion in 2025, with projections indicating it will reach around $1.46 billion in 2026. This regional segment operates within the broader Middle East and Africa context, where the combined animal health market is estimated at $5.48 billion in 2025, and the wider veterinary healthcare sector is valued at $4.08 billion.
- •Regional market valued at $1.23 billion in 2024, growing to $1.34 billion in 2025 and projected at $1.46 billion in 2026
- •Part of the larger MEA animal health market estimated at $5.48 billion in 2025 across the combined Middle East and Africa region
- •Broader regional animal healthcare market valued at $4.08 billion in 2025, anticipated to reach $4.36 billion
Growth Drivers
The market's 8.94% annual growth rate substantially exceeds the global animal health market average of approximately 2.7%, driven by distinct regional dynamics. Rising per capita income and urbanization have increased demand for animal protein, while growing middle-class populations have expanded companion animal ownership and veterinary spending. Government investments in agricultural modernization, food security initiatives, and improved veterinary service access further support sustained market expansion across Middle Eastern countries.
- •Annual growth rate of 8.94% significantly outpaces the global animal health market growth rate of approximately 2.73%
- •Regional animal feed sector expected to grow at around 3.4% CAGR during 2025-2030, supporting livestock health product demand
- •Increasing demand for animal protein and growing companion animal ownership driving veterinary product consumption
Segmentation and Regional Analysis
The market spans veterinary pharmaceuticals, biologicals including vaccines, diagnostics, and feed additives serving livestock, poultry, and companion animal segments. Growth varies across the region, with Gulf Cooperation Council countries typically showing stronger market development due to higher income levels and greater veterinary infrastructure investment compared to other Middle Eastern markets. The broader Middle East and Africa region demonstrates significant heterogeneity, with certain countries representing more developed animal healthcare markets while others present emerging growth potential.
- •Market spans livestock/poultry and companion animal segments with product categories including pharmaceuticals, vaccines, and diagnostics
- •GCC countries lead regional market development with more advanced veterinary infrastructure and higher spending capacity
- •Broader MEA market projected to reach $7.9 billion by 2033 from $5.5 billion in 2026, indicating regional expansion opportunities
Competitive Landscape
Who are the notable companies in the industry?
The regional animal health market exhibits moderate fragmentation with a mix of large integrated producers and smaller specialty manufacturers serving different market segments. Production relies primarily on established pharmaceutical manufacturing processes using bulk drug intermediates and active pharmaceutical ingredients sourced through global supply chains. Manufacturing and distribution capacity is concentrated in major regional commercial hubs, with varying levels of local production capability across different countries.
- •Market structure shows moderate fragmentation with presence of both integrated multinational producers and regional specialty manufacturers
- •Production relies on conventional pharmaceutical manufacturing routes using sourced active pharmaceutical ingredients and bulk intermediates
- •Manufacturing and distribution capacity concentrated in major regional commercial centers with varying levels of local production capability
Trends and Outlook
What are the recent trends and outlook?
The market is positioned for continued robust growth, with projections indicating sustained expansion through the forecast period. Regional focus on food security, combined with strengthening regulatory frameworks for veterinary products and growing awareness of animal health and welfare, creates favorable conditions for market development. The Middle East segment's growth rate of 8.94% positions it among the faster-growing regional animal health markets globally, supported by ongoing economic diversification and agricultural development programs.
- •Market projected to maintain strong growth trajectory through 2026 and beyond, outpacing many mature regional markets
- •Global animal health market expected to reach $51.6 billion by 2034, with regional markets like the Middle East growing at accelerated rates
- •Food security priorities and regulatory development supporting long-term market expansion and professionalization
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2026 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.